|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
CA2326598C
(en)
|
1998-04-07 |
2014-06-10 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
DK1144447T3
(da)
*
|
1998-11-04 |
2010-02-08 |
Isis Innovation |
Dianostisk tuberkulosetest
|
|
US6432916B1
(en)
|
1998-12-08 |
2002-08-13 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6565856B1
(en)
*
|
1998-12-08 |
2003-05-20 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6447779B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds for the diagnosis of Chlamydial infection
|
|
US20020061848A1
(en)
|
2000-07-20 |
2002-05-23 |
Ajay Bhatia |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6555115B1
(en)
|
1998-12-08 |
2003-04-29 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US6448234B1
(en)
|
1998-12-08 |
2002-09-10 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US7083796B2
(en)
|
2000-06-20 |
2006-08-01 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
US20030027774A1
(en)
*
|
1999-03-18 |
2003-02-06 |
Ronald C. Hendrickson |
Tuberculosis antigens and methods of use therefor
|
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
|
DK1517913T3
(da)
*
|
1999-10-07 |
2007-06-18 |
Corixa Corp |
En Mycobacterium tuberculosis-kodende sekvens til ekspression af heterologe proteiner
|
|
AU779978B2
(en)
*
|
1999-10-07 |
2005-02-24 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
US7009042B1
(en)
|
1999-10-07 |
2006-03-07 |
Corixa Corporation |
Methods of using a Mycobacterium tuberculosis coding sequence to facilitate stable and high yield expression of the heterologous proteins
|
|
US6316205B1
(en)
|
2000-01-28 |
2001-11-13 |
Genelabs Diagnostics Pte Ltd. |
Assay devices and methods of analyte detection
|
|
WO2001062893A2
(en)
*
|
2000-02-25 |
2001-08-30 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
|
GB0006692D0
(en)
*
|
2000-03-20 |
2000-05-10 |
Glaxo Group Ltd |
Epitopes
|
|
US6919187B2
(en)
|
2000-04-21 |
2005-07-19 |
Corixa Corporation |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
US20030175700A1
(en)
|
2000-04-21 |
2003-09-18 |
Ajay Bhatia |
Compounds and methods for treatment and diagnosis of chlamydial infection
|
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
US6841159B2
(en)
|
2002-01-30 |
2005-01-11 |
The United States Of America As Represented By The Secretary Of The Navy |
Rapid lateral flow assay for determining exposure to Mycobacterium tuberculosis and other mycobacteria
|
|
AU2003213118A1
(en)
|
2002-02-15 |
2003-09-09 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
|
GB0321615D0
(en)
|
2003-09-15 |
2003-10-15 |
Glaxo Group Ltd |
Improvements in vaccination
|
|
WO2005061534A2
(en)
*
|
2003-12-23 |
2005-07-07 |
Statens Serum Institut |
Improved tuberculosis vaccines
|
|
DK1797127T3
(en)
|
2004-09-24 |
2017-10-02 |
Amgen Inc |
Modified Fc molecules
|
|
US8475735B2
(en)
|
2004-11-01 |
2013-07-02 |
Uma Mahesh Babu |
Disposable immunodiagnostic test system
|
|
EP1812580B1
(en)
|
2004-11-16 |
2014-12-17 |
Crucell Holland B.V. |
Multivalent vaccines comprising recombinant viral vectors
|
|
CN100368437C
(zh)
*
|
2005-01-28 |
2008-02-13 |
中国农业科学院哈尔滨兽医研究所 |
一种诊断牛结核病的重组抗原蛋白及其制备方法
|
|
HRP20120331T1
(hr)
|
2005-04-29 |
2012-05-31 |
Glaxosmithkline Biologicals Sa |
Postupak sprječavanja ili liječenja infekcije bakterijom m. tuberculosis
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
TWI457133B
(zh)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
新穎組合物
|
|
CN100999550B
(zh)
*
|
2006-01-10 |
2010-10-06 |
中国人民解放军第三○九医院 |
结核分枝杆菌融合蛋白及其应用
|
|
CN100415771C
(zh)
*
|
2006-06-06 |
2008-09-03 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
CN101311189B
(zh)
*
|
2006-06-06 |
2010-09-08 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
CN101311190B
(zh)
*
|
2006-06-06 |
2011-08-03 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
CN101298471B
(zh)
*
|
2006-06-06 |
2011-01-19 |
中国人民解放军第二军医大学 |
激发人体抗结核杆菌的保护性免疫反应的抗原表位及其用途
|
|
RU2490024C2
(ru)
*
|
2006-06-28 |
2013-08-20 |
Статенс Серум Инститьют |
Расширение спектра т клеток для включения субдоминантных эпитопов путем вакцинации с антигенами, доставленными как белковые фрагменты или пептидные коктейли
|
|
US20090181078A1
(en)
|
2006-09-26 |
2009-07-16 |
Infectious Disease Research Institute |
Vaccine composition containing synthetic adjuvant
|
|
PT2484375T
(pt)
|
2006-09-26 |
2018-07-09 |
Infectious Disease Res Inst |
Composição para vacina contendo adjuvante sintético
|
|
CN101522218B
(zh)
|
2006-10-12 |
2012-09-26 |
葛兰素史密丝克莱恩生物有限公司 |
包含水包油乳液佐剂的疫苗
|
|
PL2086582T3
(pl)
|
2006-10-12 |
2013-04-30 |
Glaxosmithkline Biologicals Sa |
Kompozycja zawierająca adiuwant w postaci emulsji typu olej w wodzie
|
|
AU2008223951B2
(en)
|
2007-03-02 |
2014-03-27 |
Glaxosmithkline Biologicals S.A. |
Novel method and compositions
|
|
US9717788B2
(en)
|
2007-03-02 |
2017-08-01 |
Glaxosmithkline Biologicals Sa |
Method of inducing an immune response against HIV employing HIV immunogens, adenoviral vectors encoding said immunogens, and adjuvant
|
|
DK2136836T3
(en)
|
2007-04-04 |
2017-04-10 |
Infectious Disease Res Inst |
Immunogenic compositions with mycobacterium tuberculosis polypeptides and fusions thereof
|
|
CA2704178A1
(en)
*
|
2007-10-13 |
2009-04-16 |
Cornell University |
Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
|
|
KR101378240B1
(ko)
|
2008-02-22 |
2014-03-28 |
포항공과대학교 산학협력단 |
결핵 예방용 조성물
|
|
EP2315597B1
(en)
|
2008-07-25 |
2017-08-23 |
GlaxoSmithKline Biologicals S.A. |
Novel compositions and methods
|
|
PL2315834T3
(pl)
|
2008-07-25 |
2018-12-31 |
Glaxosmithkline Biologicals S.A. |
Białko rv2386c związane z gruźlicą, jego kompozycje i zastosowania
|
|
LT2315773T
(lt)
*
|
2008-07-25 |
2016-11-10 |
Glaxosmithkline Biologicals S.A. |
Polipeptidai, polinukleotidai ir kompozicijos, skirti naudoti latentinės tuberkuliozės gydymui
|
|
GB0815872D0
(en)
|
2008-09-01 |
2008-10-08 |
Pasteur Institut |
Novel method and compositions
|
|
CA2754743C
(en)
|
2009-03-10 |
2020-08-25 |
Baylor Research Institute |
Antigen presenting cell targeted anti-viral vaccines
|
|
PT2406286T
(pt)
|
2009-03-10 |
2016-08-19 |
Baylor Res Inst |
Anticorpos anti-cd40 e seus usos
|
|
DK3138854T3
(da)
*
|
2009-03-10 |
2022-04-11 |
Baylor Res Institute |
Antistoffer mod CD40
|
|
HRP20161585T1
(hr)
|
2009-06-05 |
2016-12-30 |
Infectious Disease Research Institute |
Sintetski glukopiranozilni lipidi kao adjuvansi i cjepivni pripravci koji ih sadrže
|
|
CN102869372B
(zh)
|
2010-01-27 |
2016-01-20 |
葛兰素史密丝克莱恩生物有限公司 |
经修饰的结核抗原
|
|
ES2651005T3
(es)
|
2010-03-09 |
2018-01-23 |
Biomedical Research Models, Inc. |
Una nueva estrategia de vacunación mucosa para el virus del herpes simple tipo-2
|
|
AU2011343367B2
(en)
*
|
2010-12-14 |
2015-05-21 |
Glaxosmithkline Biologicals S.A. |
Mycobacterium antigenic composition
|
|
GB201022007D0
(en)
|
2010-12-24 |
2011-02-02 |
Imp Innovations Ltd |
DNA-sensor
|
|
CN102154324B
(zh)
*
|
2010-12-29 |
2012-11-28 |
兰州大学 |
结核分枝杆菌融合蛋白Mtb10.4-Hsp16.3的构建、表达和纯化方法及其应用
|
|
EP2688592A4
(en)
|
2011-03-25 |
2015-07-22 |
Baylor Res Inst |
Compositions and methods for immunization against the hepatitis C virus
|
|
EP3632463A1
(en)
|
2011-04-08 |
2020-04-08 |
Immune Design Corp. |
Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
|
|
US20120288515A1
(en)
|
2011-04-27 |
2012-11-15 |
Immune Design Corp. |
Synthetic long peptide (slp)-based vaccines
|
|
CN102305855A
(zh)
*
|
2011-05-19 |
2012-01-04 |
中山大学 |
体外检测结核分枝杆菌感染的试剂和方法
|
|
EP2771469A4
(en)
*
|
2011-10-24 |
2015-04-08 |
Univ Central Florida Res Found |
CONCENTRATED PLASTIC-EXPRESSED MYCOBACTERIUM TUBERCULOSE VACCINE FUEL ESTATES ESAT-6 AND MTB72F AT CHOLERATOXIN B SUB-UNIT
|
|
DK2811981T3
(da)
|
2012-02-07 |
2019-06-11 |
Infectious Disease Res Inst |
Forbedrede adjuvansformuleringer, der omfatter tlr4-agonister, og fremgangsmåder til anvendelse heraf
|
|
MX347154B
(es)
|
2012-02-24 |
2017-02-21 |
Centro De Investigación Científica Y De Educación Superior De Ensenada Baja California (Cicese) |
Prueba de diagnóstico para enfermedades infecciosas en ganado bovino.
|
|
US9555099B2
(en)
|
2012-05-16 |
2017-01-31 |
Immune Design Corp. |
Vaccines for HSV-2
|
|
CN102757971B
(zh)
*
|
2012-08-07 |
2013-09-11 |
中国人民解放军第三O九医院 |
一种结核分枝杆菌重组蛋白质及其制备方法
|
|
EP2912056B1
(en)
*
|
2012-10-23 |
2020-02-12 |
Statens Serum Institut |
M. tuberculosis vaccines
|
|
US9566325B2
(en)
|
2013-01-07 |
2017-02-14 |
Biomedical Research Models, Inc. |
Therapeutic vaccines for treating herpes simplex virus type-2 infections
|
|
JP2016516075A
(ja)
*
|
2013-03-15 |
2016-06-02 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
結核の予防または治療用の合成免疫原
|
|
AU2014253791B2
(en)
|
2013-04-18 |
2019-05-02 |
Immune Design Corp. |
GLA monotherapy for use in cancer treatment
|
|
US9463198B2
(en)
|
2013-06-04 |
2016-10-11 |
Infectious Disease Research Institute |
Compositions and methods for reducing or preventing metastasis
|
|
IL310015B1
(en)
|
2013-12-31 |
2025-10-01 |
Access To Advanced Health Inst |
Single vial formulation
|
|
CN120939216A
(zh)
|
2014-01-13 |
2025-11-14 |
贝勒研究院 |
抗hpv和hpv相关的疾病的新疫苗
|
|
WO2017151818A2
(en)
*
|
2016-03-02 |
2017-09-08 |
Cue Biopharma, Inc. |
T-cell modulatory multimeric polypeptides and methods of use thereof
|
|
WO2017176076A1
(en)
|
2016-04-06 |
2017-10-12 |
Ewha University - Industry Collaboration Foundation |
A peptide with ability to penetrate cell membrane
|
|
BR112018073690B1
(pt)
|
2016-05-16 |
2022-05-24 |
Infectious Disease Research Institute |
Formulação contendo agonista de tlr e métodos de uso
|
|
EP3458028A1
(en)
|
2016-05-16 |
2019-03-27 |
Infectious Disease Research Institute |
Pegylated liposomes and methods of use
|
|
CA3023271A1
(en)
|
2016-06-01 |
2017-12-07 |
Infectious Disease Research Institute |
Nanoalum particles containing a sizing agent
|
|
KR20240096685A
(ko)
|
2017-06-15 |
2024-06-26 |
액세스 투 어드밴스드 헬스 인스티튜트 |
나노구조 지질 담체 및 안정적인 에멀션 그리고 이들의 용도
|
|
CN111315406A
(zh)
|
2017-09-08 |
2020-06-19 |
传染病研究所 |
包括皂苷的脂质体调配物及其使用方法
|
|
US10610585B2
(en)
|
2017-09-26 |
2020-04-07 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Methods and compositions for treating and preventing HIV
|
|
CN109825497A
(zh)
*
|
2019-01-25 |
2019-05-31 |
石河子大学 |
一种新型结核杆菌融合菌株的制备方法及其应用
|
|
CA3141577A1
(en)
|
2019-05-25 |
2020-12-03 |
Infectious Disease Research Institute |
Composition and method for spray drying an adjuvant vaccine emulsion
|
|
CA3266697A1
(en)
|
2022-09-09 |
2024-03-14 |
Access To Advanced Health Institute |
COMPOSITION OF AN IMMUNOGENEOUS VACCINE CONTAINING A SAPONIN
|
|
CN118652311B
(zh)
*
|
2024-07-17 |
2025-02-25 |
扬州大学 |
结核分枝杆菌复合体ⅶ型分泌系统效应蛋白cfp10保守功能性b细胞表位及其应用
|